LR Group Wins Jerusalem Tender for $130 Million Life Sciences Fund
In June, the company announced its intention to establish a network of biotech hubs in several healthcare centers in Israel and abroad
For daily updates, subscribe to our newsletter by clicking here.Founded in 1985 and headquartered in Herzliya near Tel Aviv, LR offers international project development services with a focus on sustainability. In June the company announced its intention to establish a network of biotech hubs, called Biohouse, in several healthcare centers in Israel and abroad. The first hub, located in Jerusalem-based Hadassah Medical Center, is already operational.
The fund will invest mostly in mid-stage startups in the domains of medical devices and digital health. According to the terms set in the tender, a significant part of the investment must go towards Jerusalem-based companies, but the fund is not obligated to invest only in Israeli companies.